Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Modified pep7, named EPM peptide, effectively promotes hair growth at low concentrations and works well with minoxidil.

RSPO1 could help create new diabetes treatments by increasing pancreatic β cells.

The nutritional supplement Pilopeptan® WOMAN improved hair growth and thickness in women with hair loss.

Amygdalin in Persicae Semen may help treat hair loss by promoting hair growth and regulating key pathways.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

PROTACs have become a breakthrough in medicine by effectively targeting and degrading specific proteins to treat diseases.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Purple corn extract may help reduce prostate enlargement and inflammation.

AHR ligands could treat inflammatory skin diseases.

Deslorelin implant successfully regrew hair in a female Pomeranian with alopecia X.

Allopregnanolone changes gene expression in glioblastoma cells.

Removing Gsdma1/2/3 genes reduces skin cell overgrowth by blocking a specific cell pathway.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

DHT enhances androgen receptor activity more than testosterone, and MAGE-11 influences this activity through specific interactions.

GD-23 reduces anxiety by relying on neurosteroid production.

PGD2 stops hair growth and is higher in bald men with AGA.

Panax ginseng extract helps human hair grow by encouraging growth phase transition and cell proliferation while reducing certain protein expression.

Pregnancy increases certain GABA_A receptors in rat brains, influenced by steroid levels.

Certain substances can decrease or increase exploratory behavior in rodents.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

A new method effectively predicts estrogen-related health effects for early screening.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

NAG-1 may help prevent some metabolic issues related to PCOS.